OptiBiotix Health PLC (LON:OPTI)

OptiBiotix Health PLC (LON:OPTI)

Share Price
76.40 p
-0.1 (-0.13 %)
Market Cap
£65.28 m
Proactive Investors - Run By Investors For Investors

OptiBiotix Health PLC

OptiBiotix Health PLC is a life sciences company operating in one of the most progressive areas of biotechnological research.

Developing technologies that modulate the human microbiome – the collective genome of the microbes in the body – OptiBiotix identifies and develops microbial strains, compounds and formulations for use in food ingredients, supplements and active compounds that...

Market: AIM:OPTI
52-week High/Low: 133.25p / 60.00p
Sector: Health Care, Equipment & Services
Market Cap: £65.28 m
Website: www.optibiotix.com
col 3
col 4
col 5
col 6

OptiBiotix Health PLC RNS Announcements

Date Epic Announcement
25/06/2019 OPTI Appointment of goetzpartners securities Limited
24/06/2019 OPTI Manufacturing agreement with Agropur
11/06/2019 OPTI Result of AGM
10/06/2019 OPTI License agreement for CholBiome® in Vietnam
29/05/2019 OPTI Director's Dealing
28/05/2019 OPTI Appointment of CEO of ProBiotix Health
22/05/2019 OPTI GoFigure® distribution agreement for Poland
20/05/2019 OPTI License agreement for LPLDL®
17/05/2019 OPTI Notice of AGM
14/05/2019 OPTI Distribution Agreement for SlimBiome® in Thailand
07/05/2019 OPTI License agreement for LPLDL®
02/05/2019 OPTI Investor evening
01/05/2019 OPTI SlimBiome launch to EU market at Vitafoods Europe
29/04/2019 OPTI Final Results
24/04/2019 OPTI SlimBiome® Medical launches in UK market
11/04/2019 OPTI SlimBiome® receives approval from FSSAI in India
09/04/2019 OPTI SlimBiome® Medical agreement for Bulgaria
27/03/2019 OPTI Grant of Options
27/03/2019 OPTI SweetBiotix®: Scientific and commercial update
27/03/2019 OPTI SweetBiotix®: Scientific and commercial update
25/03/2019 OPTI Price Monitoring Extension
20/03/2019 OPTI Exclusive distribution agreement for SlimBiome®
15/03/2019 OPTI Extension of term and territories for LPLDL®
13/03/2019 OPTI Exercise of Warrants
21/02/2019 OPTI LPLDL® determined GRAS by an Expert Panel in US
20/02/2019 OPTI Presentations at ProBiota - 2019
13/02/2019 OPTI Trading Statement
11/02/2019 OPTI Distribution agreement for LPLDL® in Japan
07/02/2019 OPTI Supply agreement for LPLDL® in the Baltic States
18/01/2019 OPTI Exercise of Warrants

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use